Metastatic thymic epithelial tumors: A regional cancer center experience

CONCLUSION: Adriamycin Cisplatin Vincristine Cyclophosphamide (ADOC), Cyclophosphamide Adriamycin Cisplatin, and paclitaxel + carboplatin all are viable first-line palliative CT options for mTET and showed a comparable survival in Indian patients. The present study suggested that “responders” to first-line CT and those with Stage IVa disease might have a better survival than “nonresponders” and those with Stage IVb disease, respectively.

Source: Indian Journal of Cancer - January 28, 2019 Category: Cancer & Oncology Authors: KC Lakshmaiah Tamojit Chaudhuri Govind K Babu Lokanatha Dasappa Linu Abraham Jacob M C Suresh Babu AH Rudresha KN Lokesh LK Rajeev Source Type: research